Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1187318-53-1

Post Buying Request

1187318-53-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1187318-53-1 Usage

General Description

Methyl 3-bromo-5-fluoro-2-methylbenzoate is a chemical compound with the molecular formula C9H8BrFO2. It is a derivative of benzoic acid and contains methyl, bromine, fluoro, and methyl groups. methyl 3-bromo-5-fluoro-2-methylbenzoate is commonly used as an intermediate in the synthesis of various pharmaceutical and agrochemical products. It is a white solid that is sparingly soluble in water but soluble in organic solvents. Methyl 3-bromo-5-fluoro-2-methylbenzoate is primarily used in research and development processes for the production of new drugs and agricultural chemicals. It is important to handle this compound with proper care and follow safety guidelines due to its potential hazards.

Check Digit Verification of cas no

The CAS Registry Mumber 1187318-53-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,8,7,3,1 and 8 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1187318-53:
(9*1)+(8*1)+(7*8)+(6*7)+(5*3)+(4*1)+(3*8)+(2*5)+(1*3)=171
171 % 10 = 1
So 1187318-53-1 is a valid CAS Registry Number.

1187318-53-1Relevant articles and documents

SUBSTITUTED ISOINDOLINONES

-

Paragraph 0164, (2020/06/05)

Substituted isoindolinones of Formula (I), methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds to treat or ameliorate diseases, disorders, or conditions associated with protein malfunction, such as cancer, are provided.

OXOINDOLINE DERIVATIVES AS PROTEIN FUNCTION MODULATORS

-

Paragraph 0516, (2017/12/16)

The present invention provides chimeric compounds of formula (II) that modulate protein function, to restore protein homeostasis, including cytokine, aiolos, and/or ikaros activity, TNF-alpha activity, CKl-alpha activity and cell-cell adhesion. The invention provides methods of modulating protein-mediated diseases, such as cytokine-mediated diseases, disorders, conditions, or responses. Compositions, including in combination with other cytokine and inflammatory mediators, are provided. Methods of treatment, amelioration, or prevention of protein-mediated diseases, disorders, and conditions, such as cytokine-mediated diseases, disorders, and conditions, including inflammation, fibromyalgia, rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, inflammatory bowel diseases, Crohn's disease, ulcerative colitis, uveitis, inflammatory lung diseases, chronic obstructive pulmonary disease, Alzheimer's disease, organ transplant rejection, and cancer, are provided.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1187318-53-1